Related Experiment Video
Updated: Jul 31, 2025
14:35
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
8.6K
Acute coronary complications in chronic total occlusion interventions
Pier Pasquale Leone1,2,3, Leonardo Calò4, Michael Donahue4
1Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini, 4, 20072 Pieve Emanuele-Milan, Italy.
Summary
Managing complications during chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is crucial. This review details acute coronary complications, focusing on their causes, prevention, and management strategies for successful CTO programs.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) represents a complex subset of cardiovascular procedures.
- Successful CTO programs hinge on anticipating, preventing, and managing potential complications.
Purpose of the Study:
- To review the acute coronary complications associated with CTO PCI.
- To elucidate the causes, prevention strategies, and management approaches for these complications.
Main Methods:
- Literature review focusing on acute coronary complications in CTO PCI.
- Analysis of causes, prevention, and management strategies.
Main Results:
- Acute cardiac complications can manifest directly at the coronary artery level or as non-coronary events like hypotension or arrhythmias.
- Understanding the specific causes is key to effective prevention and management.
Conclusions:
- Proactive planning and prompt recognition are vital for mitigating acute coronary complications during CTO PCI.
- Effective management strategies are essential for optimizing patient outcomes in CTO interventions.
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
17
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
17
01:27Coronary Artery Disease V: Interprofessional Care
13
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
13
01:27Peripheral Artery Disease III: Interprofessional Care
14
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
14
01:26Angina IV: Management
12
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
12
01:30Acute Coronary Syndrome I: Introduction
36
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
36
01:26Atherosclerosis III: Management
16
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16